Should Investors Be More Enthusiastic About Procter & Gamble Earnings?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Should Investors Be More Enthusiastic About Procter & Gamble Earnings?

© Public Domaine / Wikimedia Commons

Procter & Gamble Co. (NYSE: PG | PG Price Prediction) reported its fiscal first-quarter financial results before the markets opened on Thursday. The company said that it had $1.63 in earnings per share (EPS) and $19.3 billion in revenue, while consensus estimates were just $1.41 in EPS and revenue of $18.35 billion. The same period of last year reportedly had EPS of $1.37 on $17.8 billion in revenue.

During the latest quarter, net sales increased 9% year over year. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales also increased 9%, driven by a 7% increase in organic shipment volume

In terms of its segments, the company reported as follows:

  • Beauty net sales increased 7% year over year to $3.79 billion.
  • Grooming net sales increased by 5% to $1.60 billion.
  • Health Care net sales increased by 11% to $2.47 billion.
  • Fabric & Home Care increased by 14% to $6.64 billion.
  • Baby, Feminine & Family Care increased 3% to $4.72 billion.

On the books, Procter & Gamble’s cash and cash equivalents totaled $13.39 billion, down from $16.18 billion at the end of the previous fiscal year.

[nativounit]

Looking ahead to the 2021 fiscal full year, the company said that it expects to see core EPS growth in the range of 4% to 9% and all-in sales growth of 3% to 4%. Consensus estimates are calling for $5.40 in EPS and $72.93 billion in revenue for the full year.

Procter & Gamble stock traded up 1.5% early Tuesday to $144.20, in a 52-week range of $94.34 to $145.87. The consensus price target is $141.69.

[recirclink id=802167] [wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618